Ezzat S - Search Results

1

Insulin and related factors in premenopausal breast cancer risk.

Del Giudice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D, Goodwin PJ. Del Giudice ME, et al. Among authors: ezzat s. Breast Cancer Res Treat. 1998 Jan;47(2):111-20. doi: 10.1023/a:1005831013718. Breast Cancer Res Treat. 1998. PMID: 9497099

2

Insulin-like growth factor binding protein-1 is elevated in patients with polycythemia vera and stimulates erythroid burst formation in vitro.

Mirza AM, Ezzat S, Axelrad AA. Mirza AM, et al. Among authors: ezzat s. Blood. 1997 Mar 15;89(6):1862-9. Blood. 1997. PMID: 9058705 Free article.

3

Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathways.

Liu W, Asa SL, Fantus IG, Walfish PG, Ezzat S. Liu W, et al. Among authors: ezzat s. Am J Pathol. 2002 Feb;160(2):511-9. doi: 10.1016/S0002-9440(10)64870-5. Am J Pathol. 2002. PMID: 11839571 Free PMC article.

4

Growth factors and their receptors in the genesis and treatment of thyroid cancer.

Ezzat S. Ezzat S. Cancer Treat Res. 2004;122:121-9. doi: 10.1007/1-4020-8107-3_6. Cancer Treat Res. 2004. PMID: 16209041 Review. No abstract available.

5

Epigenetically controlled fibroblast growth factor receptor 2 signaling imposes on the RAS/BRAF/mitogen-activated protein kinase pathway to modulate thyroid cancer progression.

Kondo T, Zheng L, Liu W, Kurebayashi J, Asa SL, Ezzat S. Kondo T, et al. Among authors: ezzat s. Cancer Res. 2007 Jun 1;67(11):5461-70. doi: 10.1158/0008-5472.CAN-06-4477. Cancer Res. 2007. PMID: 17545628

6

Acromegaly: re-thinking the cancer risk.

Loeper S, Ezzat S. Loeper S, et al. Among authors: ezzat s. Rev Endocr Metab Disord. 2008 Mar;9(1):41-58. doi: 10.1007/s11154-007-9063-z. Rev Endocr Metab Disord. 2008. PMID: 18157698 Review.

7

The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis.

Liu W, Cheng S, Asa SL, Ezzat S. Liu W, et al. Among authors: ezzat s. Cancer Res. 2008 Oct 1;68(19):8104-12. doi: 10.1158/0008-5472.CAN-08-2132. Cancer Res. 2008. PMID: 18829569

8

Genetic and epigenetic mechanisms down-regulate FGF receptor 2 to induce melanoma-associated antigen A in breast cancer.

Zhu X, Asa SL, Ezzat S. Zhu X, et al. Among authors: ezzat s. Am J Pathol. 2010 May;176(5):2333-43. doi: 10.2353/ajpath.2010.091049. Epub 2010 Mar 26. Am J Pathol. 2010. Retraction in: Am J Pathol. 2015 Aug;185(8):2339. doi: 10.1016/j.ajpath.2015.04.025 PMID: 20348248 Free PMC article. Retracted.

9

FGFR2 isoforms support epithelial-stromal interactions in thyroid cancer progression.

Guo M, Liu W, Serra S, Asa SL, Ezzat S. Guo M, et al. Among authors: ezzat s. Cancer Res. 2012 Apr 15;72(8):2017-27. doi: 10.1158/0008-5472.CAN-11-3985. Epub 2012 Feb 17. Cancer Res. 2012. PMID: 22345151

10

Octreotide stimulates insulin-like growth factor-binding protein-1: a potential pituitary-independent mechanism for drug action.

Ezzat S, Ren SG, Braunstein GD, Melmed S. Ezzat S, et al. J Clin Endocrinol Metab. 1992 Dec;75(6):1459-63. doi: 10.1210/jcem.75.6.1281485. J Clin Endocrinol Metab. 1992. PMID: 1281485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

546 results

Search Page

Filters